Protein engineering usually involves the modification of genetically coded proteins by site-directed mutagenesis. As an alternative to this strategy, we are exploring the de novo design and chemical synthesis of nongenetic beta proteins. Our ultimate goal is to design and build nongenetic proteins containing a binding site (a receptor) or a catalytic site (an enzyme). Initial efforts will focus on two identical peptide chains held together by one or two covalent bonds, each designed to fold into an antiparallel beta-pleated sheet consisting of four beta strands connected by three beta turns. The first and third beta turns would constitute a potential active site at the open end of the barrel. Each beta sheet would have a hydrophilic face and a hydrophobic face. In aqueous solvent, this pair of amphiphilic sheets might adopt a tertiary structure having the two hydrophobic sides held together by noncovalent forces to give a small globular beta-barrel bell-shaped protein, which we call a betabellin. Alternatively, if a parallel or antiparallel beta sheet is constructed from beta strands attached to a symmetric cross linker, it might produce a small globular beta-cylindrical protein, which we call a betacylindrin. An early aim of this project is to engineer nongenetic proteins that fold into small globular structures, which may form crystals suitable for X-ray crystallography, such as crystalline betabellins having beta-barrel architecture or crystalline betacylindrins having beta-cylindrical architecture. A new and general procedure we propose for engineering of nongenetic proteins uses several applications of a four-step engineering cycle, namely, design of potentially useful variants by computer-aided molecular modeling, construction of many structural variants by combinatorial protein synthesis, selection of the desired functional variants by competition affinity chromatography, and identification of the selectyed variants by Edman sequencing. This procedure should allow the engineering of nongenetic receptor proteins by using appropriate ligands for the desired binding site in the selection step, or of nongenetic enzymes by using appropriate transition-state inhibitors of the desired catalytic site in the selection step. Intermediate goals include the engineering of betabellins with binding or catalytic sites, such as a triose phosphate isomerase, and engineering of betacylindrins with binding or catalytic sites, such as a fatty acid carrier. These tailor-made nongentic proteins may be useful for medical diagnosis or therapy.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM042031-05
Application #
2181190
Study Section
Bio-Organic and Natural Products Chemistry Study Section (BNP)
Project Start
1989-04-01
Project End
1995-03-31
Budget Start
1993-04-01
Budget End
1995-03-31
Support Year
5
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Saderholm, Matthew J; Lemon, Stanley M; Erickson, Bruce W (2007) Characterization of deltoid, a chimeric protein containing the oligomerization site of hepatitis delta antigen. Biopolymers 88:764-73
Lim, A; Makhov, A M; Bond, J et al. (2000) Betabellins 15D and 16D, de Novo designed beta-sandwich proteins that have amyloidogenic properties. J Struct Biol 130:363-70
Guy, P A; Anderegg, R J; Lim, A et al. (1999) Metal-ion binding and limited proteolysis of betabellin 15D, a designed beta-sandwich protein. J Am Soc Mass Spectrom 10:969-74
Lim, A; Makhov, A M; Saderholm, M J et al. (1999) Biophysical characterization of betabellin 16D: a beta-sandwich protein that forms narrow fibrils which associate into broad ribbons. Biochem Biophys Res Commun 264:498-504
Lim, A; Saderholm, M J; Makhov, A M et al. (1998) Engineering of betabellin-15D: a 64 residue beta sheet protein that forms long narrow multimeric fibrils. Protein Sci 7:1545-54
Zuccola, H J; Rozzelle, J E; Lemon, S M et al. (1998) Structural basis of the oligomerization of hepatitis delta antigen. Structure 6:821-30
Goldsmith, E B; Erickson, B W; Thompson, N L (1997) Synthetic peptides from mouse Fc receptor (MoFc gamma RII) that alter the binding of IgG to MoFc gamma RII. Biochemistry 36:952-9
McCafferty, D G; Friesen, D A; Danielson, E et al. (1996) Photochemical energy conversion in a helical oligoproline assembly. Proc Natl Acad Sci U S A 93:8200-4
Rozzelle Jr, J E; Wang, J G; Wagner, D S et al. (1995) Self-association of a synthetic peptide from the N terminus of the hepatitis delta virus protein into an immunoreactive alpha-helical multimer. Proc Natl Acad Sci U S A 92:382-6
Slate, C A; Weninger, S C; Church, F C et al. (1995) Engineering of five 88-residue receptor-adhesive modular proteins containing a parallel alpha-helical coiled coil and two RGD ligand sites. Int J Pept Protein Res 45:290-8

Showing the most recent 10 out of 22 publications